Skip to main content
. 2021 Apr 24;12(12):3548–3557. doi: 10.7150/jca.50292

Figure 4.

Figure 4

Lenvatinib suppressed autophagy in GBC-SD and NOZ cells. GBC-SD and NOZ cells were treated with 25 or 50 µM lenvatinib for 48 h. (A and B) Analysis of LC3II/I ration and p-62 following treatment with lenvatinib in GBC‑SD and NOZ cells, as assessed by western blotting. β-actin or GAPDH was used as a loading control. *P<0.05 vs. NC. LC3, microtubules associated proein 1 light chain 3β; NC, negative control.